Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Seizures × Cannabidiol × 90 days × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 3 Seizures 2 Lennox Gastaut Syndrome 2 Epilepsies, Myoclonic 2 Liver Cirrhosis 1 Glioblastoma 1 Chemotherapy-Induced Peripheral Neuropathy 1 Cancer Pain 1 Behavior 1

Interventions

Levetiracetam 2 Cannabidiol 2 Solutions 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05864846 2026-03-12

EpiCom

Jazz Pharmaceuticals

Phase 4 Active not recruiting

Behavior, Seizures, Tuberous Sclerosis

NCT05485831 2026-02-17

EpiTALY

Jazz Pharmaceuticals

Epilepsies, Myoclonic, Seizures, Tuberous Sclerosis, Lennox Gastaut Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡